Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs12935859 | chr17:50303719 | A/G | 3.24E-5 | 178 | 26.57 | 27.2 | 14.43 | KM Plot |
PCPG | rs12936283 | chr17:50290955 | C/T | 3.32E-5 | 178 | 27.27 | 25.97 | 14.43 | KM Plot |
PCPG | rs12936458 | chr17:50312701 | C/T | 6.48E-5 | 177 | 25.4 | 28.47 | 14.47 | KM Plot |
PCPG | rs12936870 | chr17:50314078 | C/T | 6.48E-5 | 177 | 25.4 | 28.47 | 14.47 | KM Plot |
PCPG | rs12937096 | chr17:50298441 | A/C | 5.9E-5 | 178 | 14.47 | 28.38 | 25.4 | KM Plot |
PCPG | rs12937717 | chr17:50314350 | C/T | 6.48E-5 | 177 | 25.4 | 28.47 | 14.47 | KM Plot |
PCPG | rs12939066 | chr17:50270268 | C/T | 4.36E-5 | 174 | 25.53 | 29.7 | 14.43 | KM Plot |
PCPG | rs12939544 | chr17:50309626 | G/T | 5.95E-5 | 178 | 25.53 | 28.47 | 14.47 | KM Plot |
PCPG | rs12942881 | chr17:50303770 | A/G | 6.47E-5 | 177 | 25.53 | 28.38 | 14.47 | KM Plot |
PCPG | rs12949235 | chr17:50309871 | A/C | 5.96E-5 | 178 | 14.47 | 29.7 | 25.4 | KM Plot |
PCPG | rs12950144 | chr17:50308600 | A/G | 6.17E-5 | 177 | 25.53 | 29.7 | 14.47 | KM Plot |
PCPG | rs12950394 | chr17:50308625 | A/G | 6.17E-5 | 177 | 25.53 | 29.7 | 14.47 | KM Plot |
PCPG | rs12971120 | chr18:72174023 | A/G | 2.83E-6 | 178 | 24.7 | 28.83 | 10.3 | KM Plot |
PCPG | rs12975912 | chr19:31572062 | A/G | 1.22E-7 | 175 | 24.37 | 35.23 | 19.87 | KM Plot |
PCPG | rs12988275 | chr2:24346518 | C/A | 0.000123 | 176 | 25.28 | 26.92 | 17.43 | KM Plot |